FIFTH THIRD BANCORP

Bank

Position in NVAX — Novavax Inc

CIK 35527 CINCINNATI, OH

Position in NVAX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$1,460

-$672 QoQ

Shares Held

155

-40.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#225

of 263 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 6% Shared 0% None 94%

Healthcare · as of Jun 30, 2026

FIFTH THIRD BANCORP holds $201,859,171 across 149 Biotechnology names. NVAX ranks #125 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	81,898	$40,681,193
2	REGN	Regeneron Pharmaceuticals, Inc.	29,244	$18,234,803
3	TECH	BIO-TECHNE Corp	117,371	$8,292,261
4	VCEL	Vericel Corp	185,051	$8,232,918
5	KYMR	Kymera Therapeutics, Inc.	65,659	$7,529,117
6	HALO	Halozyme Therapeutics, Inc.	95,681	$7,488,951
7	BBIO	BridgeBio Pharma, Inc.	87,238	$6,497,486
8	RARE	Ultragenyx Pharmaceutical Inc.	193,236	$6,452,150

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,460	155	-40.8%	Shares	Defined	2026-08-05
2026-03-31	$2,132	262	-74.1%	Shares	Defined	2026-05-01
2022-12-31	$10,382	1,010	0.0%	Shares	Defined	2023-01-25
2022-09-30	$18,382	1,010	0.0%	Shares	Defined	2022-10-25
2022-06-30	$51,944	1,010	0.0%	Shares	Defined	2022-08-04
2022-03-31	$74,386	1,010	0.0%	Shares	Defined	2022-04-19
2021-12-31	$144,500	1,010	0.0%	Shares	Defined	2022-02-01
2021-09-30	$209,383	1,010	0.0%	Shares	Defined	2021-10-15
2021-06-30	$214,433	1,010	-2.4%	Shares	Defined	2021-08-06
2021-03-31	$187,655	1,035	-27.4%	Shares	Defined	2021-05-07
2020-12-31	$158,901	1,425	-10.4%	Shares	Defined	2021-02-16
2020-09-30	$172,276	1,590	+50.0%	Shares	Defined	2020-11-09
2020-06-30	$88,351	1,060	+5.0%	Shares	Defined	2020-08-05
2020-03-31	$13,715	1,010	—	Shares	Defined	2020-05-05
No filing history on record for this holder in this stock.